Caloric restriction without malnutrition extends lifespan from yeast to primates. The NIA's rhesus macaque study showed that 30% restriction starting in adulthood cut age-related mortality by 2.6-fold and delayed diabetes, cancer, cardiovascular disease, and brain atrophy (Colman et al., 2009; Mattison et al., 2017). Whether humans get the same deal has been the open question.

CALERIE Phase 2 was the first randomized controlled trial of sustained caloric restriction in healthy, non-obese humans. Three U.S. sites, 218 adults aged 21 to 50, randomized to either 25% caloric restriction or ad libitum eating for 2 years. In practice, the CR group averaged about 12% restriction, less than targeted but still metabolically meaningful. Redman et al. (2018) published the primary results in Cell Metabolism: improved cardiometabolic risk factors, lower oxidative stress, and better thyroid function.

The real advance came when Belsky et al. (2023) applied the DunedinPACE epigenetic clock to stored CALERIE blood samples. DunedinPACE measures how fast someone is aging right now, not cumulative biological age. The CR group was aging 2 to 3% slower than controls (P < 0.01). Extrapolated over decades, that translates to a projected 10 to 15% reduction in mortality risk.

This new follow-up extends the clock data to 4 years post-randomization, including 2 years after participants went back to eating whatever they wanted. The slowing persisted: treated participants still aged 1.8% slower than controls (P < 0.05). Slightly weaker than the on-treatment effect, but the fact that it held at all suggests CR rewired something in the epigenetic landscape, not only in the metabolism.

Molecular analysis supports that interpretation. DNA methylation profiling showed sustained hypomethylation at inflammatory gene promoters and persistent hypermethylation at loci tied to insulin signaling and mTOR pathway activity. These epigenetic marks hadn't reverted 2 years after the diet ended. The pattern is consistent with CR resetting age-associated epigenetic drift at specific genomic regions.

The practical takeaway: about 300 fewer calories per day, much less severe than the 30% restriction used in animal studies, appears to slow the biology of aging in healthy people. Belsky et al. estimate, using Framingham Heart Study mortality curves, that a sustained 2 to 3% pace reduction would reduce all-cause mortality by 10 to 15% over a decade.

The persistence of benefits after resuming normal eating matters for public health messaging. Temporary periods of caloric discipline may yield lasting returns. Several groups are testing whether intermittent fasting or periodic fasting-mimicking diets (Brandhorst et al., 2015) can reproduce CR's epigenetic effects with compliance rates that are realistic for most people.